Previous studies have implicated the circadian system in the pathophysiology of bipolar disorder, but conclusive evidence for altered circadian clocks is lacking. Cultured fibroblasts harbor circadian clocks representative of those in the master clock resident in the suprachiasmatic nuclei, providing a new avenue to investigate the core clock machinery in patients with bipolar illness. We examined the rhythmic expression patterns of core clock genes (BMAL1, PER1, PER2, REV-ERBa, DEC2, DBP) in fibroblasts from 12 bipolar patients and 12 healthy controls. Although we did not detect differences in the circadian period between bipolar patients and controls, the amplitude of rhythmic expression for BMAL1, REVERBa and DBP, as well as the overall mRNA expression level for DEC2 and DBP was reduced in fibroblasts from bipolar patients. Bonferroni's correction for multiple comparisons still resulted in significantly reduced DBP expression level, and trends toward reduced overall expression level of DEC2 and circadian amplitude of BMAL1, in fibroblasts from bipolar patients. We next examined an expanded cohort of 18 bipolar patients and 35 healthy controls for mRNA expression levels of four kinases (CKId, CKIe, GSK3a and GSK3b) and the protein and phosphorylation levels of two of them (GSK3a and GSK3b). We did not detect differences in steady-state mRNA levels or protein levels of these kinases between bipolar patients and controls, but the level of GSK3b phosphorylation was significantly reduced in bipolar patients within an Old Order Amish bipolar kindred. Our results suggest that the reduced amplitudes and overall expression levels of circadian genes, and the decreased phosphorylation level of GSK3b may lead to dysregulation of downstream genes, which could explain some pathological features of bipolar disorder.
Introduction
Bipolar disorder, characterized by episodes of mania or hypomania interspersed with periods of depression, is a common psychiatric illness affecting 2.6% of the US population. 1 Genetic linkage and association studies have assigned susceptibility loci for bipolar disorder to several chromosomal segments. 2 However, these regions span several megabases and contain hundreds of genes. Due to the disorder's complex nature, definitive identification of susceptibility alleles has been difficult. It is therefore critical to explore novel approaches in an effort to understand the molecular basis of this condition.
Circadian abnormalities have long been suggested to be involved in the pathogenesis of bipolar disorder. 3, 4 Changes in rest:activity and sleep:wake cycles are among the most prominent aspects of bipolar illness during both the manic and depressed phase (see references [5] [6] [7] for reviews). In bipolar patients, alterations in phase, period and amplitude of circadian rhythms have been documented by measuring core temperature, hormonal secretion or actigraphy. [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] In addition, lithium, the most effective treatment for bipolar disorder 22, 23 lengthens the circadian period in mammalian cells [24] [25] [26] and in model organisms. [27] [28] [29] Lithium treatment of 293T cells leads to rapid proteosomal degradation of REV-ERBa and transcriptional activation of BMAL1, 30 which are critical components of core clock mechanism. Furthermore, suggestive evidence has recently been reported for the association of circadian gene variants including CLOCK, BMAL1, PER3 and TIMELESS with bipolar disorder. [31] [32] [33] Moreover, studies using pharmacogenomic animal models for bipolar disorder have revealed circadian genes as the candidate genes for mania and psychosis, which include BMAL1, GSK3b, CKId, CRY2 34 and DBP. 35 Despite the above-mentioned evidence implicating the circadian system in the pathophysiology of bipolar disorder, the functional and molecular basis of circadian anomalies in bipolar disorder has not been elucidated. In mammals, the pacemaker and principal oscillator driving circadian rhythms are located in the suprachiasmatic nuclei (SCN) of the anterior hypothalamus. [36] [37] [38] The core clock mechanism in the mammalian SCN involves positive and negative transcriptional/translational feedback loops, which drive daily rhythms in the RNA and protein levels of key clock components. 39, 40 The positive feedback loop is composed of CLOCK and BMAL1 heterodimer which activates Period (PER1, PER2 and PER3) and Cryptochrome (CRY1 and CRY2) transcription. [41] [42] [43] [44] The negative feedback loop involves rhythmic inhibition of the transcriptional activity of CLOCK/BMAL1 by the PER and CRY complexes. [45] [46] [47] [48] These negative regulators also suppress the expression of REV-ERBa which inhibits BMAL1 transcription through RORE elements in the BMAL1 promoter. 49, 50 Another component of the feedback loop involves DEC1 and DEC2 which repress BMAL1/CLOCK-induced gene transcription, 51 and their functions as clock-controlled genes has also been revealed. 52 In addition, the PAR-leucine zipper transcription factor albumin D element-binding protein (DBP) is a first-order clock-controlled gene directly regulated by BMAL1/ CLOCK; 53 it also plays a role in the core clock by activating Per1 transcription. 54 Kinases such as CKId, 55, 56 CKIe 57,58 and GSK3b 25, 59 play an important role in phosphorylation of clock proteins, thus regulating the activity, nuclear entry and degradation of various core clock components. Among these kinases, GSK3b is of particular interest here because it was reported to be one of the direct targets of lithium, 60 which is an effective therapy for bipolar disorder. 22, 23 The activity of GSK3b can be inhibited by lithium, 60 which results in the phosphorylation of GSK3b at Ser9, 61 and the level of p-GSK3b indicates the activity of GSK3b. 28 Similar to the circadian pacemaker in the SCN in mammals, cultured cells, including fibroblasts, harbor self-sustained and cell-autonomous circadian clocks that persist even during cell division. [62] [63] [64] The circadian oscillators in cultured cells can be synchronized by treatment with 50% serum (so-called serum shock) or with various chemicals (that is, glucocorticoid, endothelin, forskolin, and so on) which elicit different signaling pathways. [65] [66] [67] [68] [69] [70] This makes it possible to detect the circadian gene expression by conventional methods such as real-time quantitative PCR (Q-PCR) or luminescence reporter assays. [62] [63] [64] Several studies have shown that the circadian oscillators in fibroblasts are similar to those operative in the SCN, and fibroblasts may serve as a valid in vitro model for molecular oscillators in the brain. 64, [70] [71] [72] The periods for the circadian gene expression in fibroblasts have been found to correspond well with human circadian physiology and mouse behavior. 71 Although the luminescence reporter assay has the advantage of higher throughput and being less laborious, it is not readily applicable to accurately measure amplitude and overall level of the expression of more than one gene. Therefore, we used Q-PCR to assess the function of the core clock machinery in serum-stimulated fibroblasts derived from bipolar patients and healthy controls. We monitored the gene expression of 10 core clock genes (BMAL1, PER1, PER2, REV-ERBa, DEC2, DBP, CKId, CKIe, GSK3a and GSK3b). Our results provide no evidence that the core clock in fibroblasts from bipolar patients, as compared to controls, has different circadian period, but altered amplitude, expression and phosphorylation levels were observed in several clock components.
Materials and methods

Source of cell lines
A collection of fibroblast cell lines prepared from skin biopsies of bipolar patients and healthy controls was purchased from the Coriell Cell Repositories-Coriell Institute for Medical Research (http://coriell.umdnj. edu/). Our experiment of circadian gene expression involved the analysis of 12 fibroblast cell lines from patients with type I bipolar disorder (BPI), and 12 unrelated control cell lines from age-, gender-and ethnicity-matched unrelated healthy subjects (MC) (Supplementary Table 1 ). In addition, five age-and gender-matched unaffected family members served as another set of controls (related controls) for 5 of the 12 bipolar cell lines. To examine steady-state mRNA and protein levels, we expanded the set of fibroblasts to 68 by including additional fibroblast cell lines of a large Old Order Amish kindred with bipolar disorder from the Coriell Cell Repositories (Supplementary Table 1 ). Among the 68 samples, 18 were BPI and 35 were unaffected controls. Updates on the diagnoses were obtained in 2006 using previously described diagnostic tools. 73 Information for the cells including age and gender of the cell donor, age of onset of bipolar disorder and the cell passage number at the time of the experiment were recorded for covariate analyses.
Tissue culture
The cells were cultured at 37 1C in humidified atmosphere containing 5% CO 2 in Dulbecco's modified Eagle's medium, supplemented with 15% fetal bovine serum (FBS) and 1% penicillin/streptomycin/ amphotericin B. The cells were seeded to six-well plates with each well containing an individual cell line. After reaching confluence, the cells were starved for 24 h in a medium containing 0.5% FBS. Then the serum shock was performed by increasing the FBS to 50%. The start of serum shock was defined as time 0. After 2 h, the medium was replaced with medium containing 0.5% FBS. The cells on the six-well plates were collected at a series of time points from 0 min to 72 h, that is, 0, 30 min, 1, 2, 4, 8, 12 h and so on. The cells were used without serum shock to examine the steady-state gene expression levels. Staining with Trypan blue did not reveal extensive cell death even after prolonged culture for 7 days after the cells reach confluence in either growth medium or a medium containing 0.5% FBS.
RNA isolation and real-time quantitative-PCR
The procedure is described in detail elsewhere. 74 Briefly, the cells were harvested and homogenized using QIAshredder (Qiagen, Hilden, Germany), and whole-cell (total) RNA was isolated using Qiagen's RNeasy mini kit (Valencia, CA, USA). The total RNA was reverse transcribed into cDNA using the cDNA Archive Kit (Applied Biosystems, Foster City, CA, USA). TaqMan assays for BMAL1, PER1, PER2, REVERBa, DEC2, DBP, CKId, CKIe, GSK3a and GSK3b and the endogenous control large ribosomal protein (RPLP0) were purchased from Applied Biosystems. All experiments were done with each sample in triplicate. Relative quantification (Q-PCR) was performed on the ABI Prism 7900HT system (Applied Biosystems). We used the program accompanying the ABI Prism 7900HT system, SDS2.2 to obtain the C t values for each sample at the different time points. The C t values were averaged for the three replicates, which were then analyzed using the DDC t method to get the DC t , DDC t and the relative mRNA quantity (RQ) according to User Bulletin no. 2 for ABI Prism 7700 Sequence Detection System (Applied Biosystems). The RQ at all time points for all cell lines were normalized to matched control no. 1 (MC01, Coriell ID no. GM02447) at 0 min, thus allowing for the comparison of overall expression level in addition to period length and amplitude.
Western blot
A previously described procedure 74 was modified. Briefly, the cells were lysed in lysis buffer: 20 mM Tris-Cl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 0.5 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 0.1% SDS, 0.5% sodium deoxycholate, 1% proteinase inhibitor cocktail P-8340 (Sigma, St Louis, MO, USA), 1% phosphatase inhibitor cocktails I and II (Sigma). The homogenates were sonicated and centrifuged at 10 000 g at 4 1C for 10 min. The supernatants were applied to SDS-polyacrylamide gel electrophoresis (PAGE) and the protein was transferred to a polyvinylidene difluoride membrane (Immobilon-P, Millipore, Bedford, MA, USA). The blot was blocked at room temperature for 1 h in 5% FBS dissolved in Trisbuffered saline supplemented with 0.05% Tween 20. The primary antibodies used were pGSK3b (S9) and pGSK3a/b (S21/9) (Cell signaling, Danvers, MA, USA), GSK3a/b (Calbiochem, La Jolla, CA, USA) and anti-b-actin (clone AC-15, Abcam, Cambridge, MA, USA). The secondary antibodies were HRPconjugated sheep anti-mouse immunoglobulin G (IgG) or HRP-conjugated monkey anti-rabbit IgG (Amersham Biosciences, Piscataway, NJ, USA). The sample from cell line GM05984 served as a reference across SDS-PAGE gels. The protein amount was quantified using ImageJ (http://rsb.info.nih.gov/ij/) and normalized to GSK3b (for pGSK3b), GSK3a (for pGSK3a) or b-actin (for GSK3b and GSK3a).
Data analysis
To investigate the early response to serum shock of BMAL1, PER1, PER2, REV-ERBa, DEC2 and DBP, the RQ data normalized to one of the healthy control (GM02447) at 0 min were considered for time points 0, 0.5, 1, 2, 4 and 8 h after serum shock. These data were subjected to mixed-effects analysis of variance (ANOVA) 75, 76 with a main effect for time (repeated measures), a main effect for group (bipolar cell lines vs matched controls (MCs)), an interaction term and a random effect on the intercept to account for interindividual differences.
To investigate the circadian profile of gene expression, after the early response had subsided, data were considered from 12 to 72 h after serum shock. These data, collected at 4-h intervals, were also subjected to mixed-effects ANOVA, as above. Contingent upon a significant effect of time, the data were then subjected to nonlinear mixed-effects harmonic regression, 77, 78 with an exponential decay curve superimposed on it to allow for damping. A random effect was placed on the intercept to account for inter-individual differences. This regression model was of the general form:
where t stands for time, A is the circadian amplitude, B is the damping rate, DT is the deviation of the circadian period from 24 h, and C i is the intercept with a subject-specific adjustment (random effect). For a given gene, the circadian phase of expression j was assumed to be the same across the two groups as it was set by the serum shock. One-sample t-tests on the circadian amplitude estimates for each group were used to detect rhythmicity. Paired t-tests were used to compare circadian period and amplitude, as well as damping rate and overall expression (intercept), between groups (bipolar cell lines vs MCs). The Bonferroni's method was applied to correct for multiple comparisons in the main analyses by multiplying original P-values by 6, the number of comparisons.
For the mRNA levels of the four kinases CKId, CKIe, GSK3a and GSK3b, RQ for cells without serum shock were used to investigate steady-state expression levels. Unpaired t-tests were applied to compare steady-state levels between groups (bipolar patients vs MCs). For the protein levels of GSK3a and GSK3b, and the phosphorylation of GSK3a and GSK3b, unpaired t-tests were performed on normalized intensities to compare fibroblasts from bipolar patients with unaffected controls in the Amish pedigree.
Analyses were repeated with age, gender, cell line passage and age of disease onset as covariates for the intercept and, in the harmonic regression analyses, also for period, amplitude and damping rate. Regression and statistical analyses were performed in SAS 9.1.3 (SAS Institute Inc., Cary, NC).
Results
To assess circadian rhythms of cultured, serum-stimulated fibroblasts derived from bipolar patients and MCs, we monitored the expression levels of six core clock genes (PER1, PER2, REV-ERBa, BMAL1, DEC2 and DBP) by real-time Q-PCR in samples from 0 to 72 h after the onset of serum shock (OSS) in fibroblasts cell lines from 12 patients with BPI and 12 healthy MCs. The 24 anonymous fibroblast donors were of varying age (BPI: 37.4 ± 14.1; MC: 38.2 ± 13.5) and gender (six males and six females in each group). Bipolar patients had different age of onset of the first manic or depressed phase (25.6±6.8). The fibroblast cells used in our study were at different number of passages (BPI: 8.7 ± 2.8; MC: 10.2 ± 3.7). To examine the effects of these factors on gene expression, we repeated all analyses including age, gender, age of disorder onset and cell passage as covariates. The steady-state expression levels of four kinases that function in the circadian system (CKId, CKIe, GSK3a and GSK3b) were examined in an expanded set of cell lines (including 18 BPI and 35 normal controls) without serum shock, and the analysis was also repeated with age, gender and cell passage as covariates.
Covariates
Our analyses revealed more profound effects of cell passage on gene expression than the other covariates. In the harmonic regression analyses of circadian rhythm, cell passage contributed significantly to the early response of REV-ERBa (increase by 0.028±0.014 per passage, P = 0.044), PER2 (decrease by 0.107 ± 0.048 per passage, P = 0.027) and DEC2 (increase by 0.077±0.031 per passage, P = 0.015), the overall level of PER1 (increase by 0.020 ± 0.009 per passage, P = 0.037) and DBP (increase by 0.106 ± 0.022 per passage, P = 0.001) and the amplitude of REV-ERBa (decrease by 0.134±0.053 per passage, P = 0.028). Passage also affected the steady-state mRNA level of GSK3a (increase by 0.061±0.017 per passage, P = 0.001). Age significantly affected the early response of PER1 (decrease by 2.707 ± 1.203 per year, P = 0.026), and the amplitude (decrease by 3.476 ± 1.422 per year, P = 0.033) and damping (increase by 1.422±0.634 per year, P = 0.046) of DBP. Gender contributed to the early response of PER1 (decrease by 0.835 ± 0.312 in female than that in male, P = 0.008) and PER2 (decrease by 0.995 ± 0.426 in female than that in male, P = 0.021), the overall level of PER1 (decrease by 0.189±0.058 in females than that in males, P = 0.008), the amplitude and period of PER2 (increase by 0.375 ± 0.155 in females than that in males in amplitude, P = 0.034; increase by 0.697 ± 0.227 h in females than that in males in period, P = 0.011) and the amplitude of REV-ERBa (increase by 0.582 ± 0.264 in females than that in males, P = 0.050). Age of onset of the disease affected the period of REV-ERBa expression (increase by 0.370 ± 0.126 h per year, P = 0.019). In most cases, correcting for the effects of passage, but not the other factors, altered the statistical significance of the original comparisons. Therefore, the results presented below are corrected for passage effects. In addition, we performed all statistical analysis without correction for covariates (Supplementary Materials), and observed that correcting for covariates did not alter the main conclusions of the paper.
Early response
We analyzed the expression of BMAL1, PER1, PER2, REV-ERBa, DEC2 and DBP in response to serum shock in fibroblasts from time 0 to 8 h after OSS. Three genes, PER1, PER2 and DEC2, showed considerably increased transcription from 30 min after OSS, with peak expression of 2 h after OSS (Figure 1a) . A marked decrease in the expression of REV-ERBa and DBP was detected starting 1 and 2 h after OSS, respectively, and a minimum level of expression was reached at 4 and 8 h after OSS, respectively, with a gradual rebound thereafter (Figure 1a) . The transcription of BMAL1 continued to rise in the first 8 h after OSS. There were no statistically significant group differences or group by time interactions between BPI and MC in the early response of these genes, except for DBP.
Circadian gene expression
Contingent upon a significant effect of time in mixedeffects ANOVA, which was consistently observed (P < 0.005 in all cases), nonlinear mixed-effects harmonic regression analyses were performed to examine BMAL1, PER1, PER2, REV-ERBa, DEC2 and DBP expression across the 3-day period (12-72 h) after OSS (Figure 1b ). This analysis quantified rhythmic patterns in the data while accounting for individual differences, and was used to examine circadian parameters including length of period, amplitude, damping and overall expression level. We detected robust oscillating patterns of mRNA levels of BMAL1, PER1, PER2, REV-ERBa and DBP for the BPI and MC groups (circadian amplitude: P < 0.001 in all cases). Although the harmonic regression analysis did not reveal significant circadian amplitudes for DEC2, a cycling expression pattern with relatively low amplitude can be still seen in the group-averaged data (Figure 1b) .
Circadian period. We compared the oscillating periods between BPI and MC for the expression of each of the six genes BMAL1, PER1, PER2, REV-ERBa, DEC2 and DBP. The periods of their expression ranged from 23.96 h (DBP in MC) to 25.47 h (DEC2 in BPI). No significant circadian period differences were detected between BPI and MC for individual genes (Figure 2a , and Supplementary Figure 2a for results without correction for passage effects), although statistical power for these comparisons was limited by the relatively short duration of the time series (three cycles). We found that circadian periods in different individuals (detected with several genes) were highly variable (data not shown), as reported in previous fibroblast analysis using luminescence reporters. 71 Circadian amplitude. We defined the amplitude of gene expression for each of the cycling genes at 12 h after OSS, with an exponential decay curve superimposed on the data from 12 to 72 h to account for damping. We selected 12 h after OSS as the point to estimate amplitude because at this time point the early response had subsided and the effect of damping was still small. We detected significant damping in the cycling expression of BMAL1, PER1, PER2 and REV-ERBa (though the damping rates for these genes were not significantly different between BPI and MC) (data not shown).
The amplitude of BMAL1 expression in BPI was significantly reduced by 38% as compared to MC (P = 0.010, Figure 2b ). The amplitude of DBP expression was reduced by 35% in BPI as compared to MC and tended to significance (P = 0.086). The amplitude of REV-ERBa expression was reduced by 27% in BPI as compared with MC, also tending to significance (P = 0.064, Figure 2b ). Although none of these remained significant after Bonferroni's correction for multiple comparisons, the expression of BMAL1 still showed a trend toward reduced amplitude in fibroblasts from bipolar patients as compared with controls (Bonferroni-adjusted P = 0.06). Without correcting for passage, the reduction of the amplitude of BMAL1, REV-ERBa and DBP in BPI remained significant even after adjusting for multiple comparisons (Supplementary Figure 2b) . The amplitudes of the rhythmic expression of PER1, PER2 and DEC2 were not significantly different between BPI and MC.
Overall expression level. We determined the overall mRNA expression levels for each cycling gene across time points 12-72 h after serum shock by evaluating the intercept of the mixed-effects harmonic regression. The overall expression level of DBP was reduced by 26% in BPI as compared to MC (P < 0.001), which remained significant after adjustment for multiple comparisons (Bonferroni-corrected P < 0.006; Figures  1b and 2c) . The overall DEC2 level was 19% lower in BPI than that in MC (P = 0.016, Figures 1b and 2c) , which tended to significance after adjustment for multiple comparisons (Bonferroni-corrected P = 0.096). Without passage correction, DEC2 level was significantly lower in BPI even after adjusting for multiple comparisons (Bonferroni-corrected P = 0.012; Supplementary Figure 2c) . The overall PER2 level was 6% reduced in BPI as compared to MC, tending to significance (P = 0.067) but failing to pass significance after Bonferroni's correction. Likewise, the overall REV-ERBa level was 7% reduced in BPI as compared to MC, but only tending to significance (P = 0.10) without passing significance after Bonferroni's correction. The overall mRNA levels of BMAL1 and PER1 were not significantly different between BP and MC. We further performed the same experiment for early response and circadian gene expression in five additional fibroblast cell lines from age, gender and family matched controls (we were able to obtain fibroblasts from siblings of five of the BPI examined in our study). We expected that cell cultures established from members of the same family would show less variability due to similar experimental conditions (same or similar protocols for collection of biopsies and site of the biopsy) and greater genetic homogeneity. Our analysis on the five BPI fibroblasts and the five related control cell lines (RC) gave similar results as compared with those of the 12 BPI cell lines with the 12 unrelated control cell lines (Supplementary Figure 1 and 3) , that is, no difference was detected in period length between the five BPI and the five matched related controls ( Supplementary  Figure 3a) , BMAL1 mRNA showed a trend to reduced amplitude (P = 0.068, Supplementary Figure 3b ) and DEC2 mRNA level was significantly reduced in bipolar cells even after adjustment for multiple comparisons (Bonferroni-corrected P < 0.006, Supplementary Figure 3c ). However, PER2 mRNA levels were significantly higher in bipolar fibroblasts as compared to the related controls (Bonferronicorrected P = 0.006, Supplementary Figure 3c) . Steady-state mRNA levels In addition to several transcription factors and cofactors with circadian patterns of expression, four kinases (CKId, CKIe, GSK3a and GSK3b) play an important role in regulating the circadian clock, although they are not rhythmically expressed. We examined their steady-state mRNA levels in the same 24 fibroblast lines used in the experiment of circadian gene expression. The mRNA levels of CKIe, GSK3a and GSK3b were not significantly different between the 12 BPI and 12 unrelated control fibroblasts, but CKId mRNA was significantly higher in the 12 BPI fibroblasts as compared with the 12 unrelated controls (P = 0.001, adjusted by passage, data not shown). However, when we expanded the set of fibroblasts by including additional fibroblast lines from the Old Order Amish pedigree (Supplementary Table 1 ), the steady-state mRNA levels of GSK3a, GSK3b, CKId and CKIe were not significantly different between BPI and normal controls (Figures 3a-d) .
We also examined the average DEC2 mRNA level in these cells without serum shock. In agreement with the reduced overall mRNA level in serum-shocked cells as described above, DEC2 mRNA was significantly reduced in fibroblasts from BPI patients as compared with unaffected controls (P = 0.01, adjusted by passage, Figure 3e ).
Level of phosphorylated form of GSK3b
To examine the basal activity of GSK3b in bipolar disorder, we examined the levels of GSK3b and p-GSK3b (S9) in fibroblast cell lines by western blotting. Our data indicated that the level of p-GSK3b, but not the total GSK3b, was much more variable in fibroblasts derived from different families than that in fibroblasts derived from a single family (Amish family no. 884, Supplementary Figure 4) . This variability was not attributable to cell passage, nor was it attributable to cell donors' gender, age, disease status, age of disease onset or history of therapeutic treatment (data not shown). We postulated that the genetic heterogeneity may be responsible for the variable p-GSK3b levels in fibroblasts of unrelated origin, that is, the members of unrelated families. Consistent with this hypothesis, our ongoing comparative studies on lymphoblastoid cell lines derived from monozygotic twins indicate that genetic factors play an important role in the regulation of GSK3b and p-GSK3b levels (data not shown).
To control the confounding effect of genetic heterogeneity that may underlie the large variance of p-GSK3b levels, and to minimize the confounding effect of anatomic positions of the skin biopsy on the expression of GSK3b, which is differentially expressed depending on the site of biopsy, 79 we restricted our analysis to the samples from the Amish pedigree. We found no difference in protein levels of GSK3b between BPI patients (n = 11) and unaffected controls (n = 22) (Figures 4a and b and Supplementary Figure 5) . However, the level of p-GSK3b (S9) was significantly lower in fibroblasts of BPI patients as compared to unaffected controls in this family (P = 0.002, Figures 4a and c and Supplementary Figure 5) , which remained significant after adjustment of multiple comparisons regardless of whether cell passage is used as a covariate in the analysis (data not shown). The levels of GSK3a and p-GSK3a (S21) in the Amish samples were not significantly altered in fibroblasts from BP patients as compared to healthy controls (Figures 4d and e and Supplementary Figure 5) .
Discussion
Evidence for altered circadian rhythms in bipolar disorder comes from studies on sleep, body temperature cycles and hormonal secretion profiles. [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [80] [81] [82] However, molecular evidence for altered circadian clock in bipolar disorder is still lacking. It has been reported that similar components of the clock machinery underlie rhythmic gene expression in cultured fibroblasts as in the central clock in the SCN. 64, 70, 72 Based on this finding, we investigated properties of circadian oscillators in fibroblast cell lines from patients with bipolar disorder. We found that core genes of the circadian clockwork-BMAL1, PER1, PER2, REV-ERBa, DEC2 and DBP-show similar rhythmic expression pattern in fibroblasts from bipolar patients and healthy controls. The passage of the fibroblast cells affected gene expression more profoundly than the age, gender or age of disease onset of the fibroblast donors. In passagecontrolled analyses, we observed no difference in circadian period between disease and control groups. Nevertheless, there was a trend toward reduced amplitude of circadian expression of BMAL1 in BP, significantly reduced or a trend toward reduced overall levels of expression of DBP and DEC2 in bipolar patients and decreased level of phosphorylated GSK3b in an Amish pedigree with bipolar disorder.
Monitoring circadian gene expression in fibroblasts established from skin biopsies did not reveal any statistically significant difference in the period length between bipolar patients and healthy controls. This result is not consistent with previous reports on shortened or lengthened circadian period, 8, 21 but those findings were obtained in whole-human recordings and were potentially confounded by considerable masking. 83 The circadian periods in cultured serum-stimulated fibroblasts normally correspond well with the circadian periods of human physiology or mouse behavior; however, discrepancy between behavioral rhythms and molecular cycles in fibroblasts in the same mouse has been reported. 71 Although circadian physiology and sleep-wake behavior are controlled by the master clock in the SCN, environmental cues or projections from other brain circuits including brain stem and cortex also modify behavior. 84 Nonetheless, our sample size was relatively small, and subtle differences in circadian period may have gone unnoticed due to limited statistical power.
Altered overt circadian rhythms have been reported in bipolar patients, including blunted amplitudes of body temperature and plasma thyroid-stimulating hormone, 16, 17, 20, 21 reduced urinary 3-methoxy-4-hydroxyphenylglycol amplitude, 12 blunted circadian amplitude of plasma tryptophan concentrations, 9 decreased serum melatonin, 14 abnormal activity level 13, 19 and increased amplitude of cortisol. 10, 11, 15, 18 We present molecular evidence for a reduction (either statistically significant or trending toward significance) in the amplitudes (for BMAL1, REV-ERBa and DBP) and in the overall levels (for DEC2 and DBP) of circadian gene expression in fibroblasts from bipolar patients. BMAL1, the key transcription factor heterodimerizing with CLOCK or NPAS2, drives circadian expression of other clock genes and the clockcontrolled genes. 38, [85] [86] [87] REV-ERBa is another core clock gene whose expression is regulated by the BMAL1/CLOCK heterodimer, and REV-ERBa in turn represses BMAL1 expression.
49 DEC2 and DBP are both involved in the core clock network, 51, 54 but they have been also considered clock-controlled genes responsible for downstream gene regulation. 52, 53 We propose that altered amplitude in the core clock mechanism may lead to transcriptional changes (either amplitude or overall expression level or both) in clock-controlled genes, which may contribute to the pathogenesis of bipolar disorder. Consistence with our hypothesis, attenuated expression of mBmal1 in SCN was reported to accompany disrupted rest-activity patterns in mouse models. 88 Furthermore, the CLOCK mutant mice, which have reduced pacemaker amplitude, 89 showed mania-like behavior. 90 It has been reported that reduced amplitude of circadian oscillators can increase the efficacy of perturbing agents such as light and other stimuli in causing phase shifts in various organisms. 89, [91] [92] [93] Although the observed reduction in the amplitude of circadian gene expression in BPI was subtle and only showed a trend for significance after correction for multiple comparisons, it is possible that the core clocks in bipolar patients are more vulnerable to external stimulation, which may contribute to unstable or more variable circadian rhythms as have been observed in bipolar patients. 13, 94, 95 Alterations in the overall expression level of core clock genes and clock-controlled genes can lead to anomalies in the circadian rhythmicity. For example, increased expression level of Per1 resulted in reduced amplitude of oscillations in the expression of Per2, RevErba and Bmal1. 96 Disruption of prokineticin 2, a clockcontrolled gene indicated as a candidate SCN clock output signal, led to reduced rhythmicity for a variety of physiological and behavioral parameters. 97 Likewise, reduction in the mRNA level of DEC2 and DBP may result in the dysregulation of their downstream target genes, which may contribute to the risk for bipolar disorder. It has been shown that Dbp expression is upregulated 24 h after methamphetamine treatment in the prefrontal cortex in a pharmacogenomic rat model of mania. 35 It is worth noting that Dbp knockout mice show a baseline depression-like phenotype, with a manic-like activation in response to stress. 98 We did not detect significant alteration in the amplitude or overall mRNA levels of circadian genes PER1, PER2 but only a tendency toward reduced amplitude in BPI samples. It is possible that the amplitude reduction of BMAL1 (which drives the expression of PER1 and PER2) is too subtle to significantly alter their expression amplitude. On the other hand, other clock-controlled genes (DEC2 and DBP, for instance) may be more sensitive to subtle changes in BMAL1 amplitude leading to cellular or behavioral changes.
We did not detect differences in the mRNA levels of CKId, CKIe, GSK3a and GSK3b in fibroblasts from bipolar patients as compared with normal controls. However, the level of the phosphorylated form of GSK3b was significantly reduced in fibroblasts from bipolar patients within an Amish family, although the total protein level of GSK3b was not changed. This result suggests that in bipolar disorder, at least in certain pedigrees, the activity of GSK3b is higher than in healthy controls. It was reported that transgenic mice overexpressing GSK3b recapitulate hyperactivity as observed in the manic phase of bipolar disorder. 99 Our result suggests that the decreased Normal N=22 GM05926  GM05932  GM05988  GM05990  GM06028  GM06024  GM05984  GM05915  GM05897 pGSK3β (S9)
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Figure 4 Lower level of p-GSK3b (S9) in fibroblasts from bipolar patients in an Amish family 884. (a) Representative western blots of two or three experiments showing the amount of pGSK3b (Ser9), GSK3a and GSK3b, using b-actin as endogenous control and sample GM05984 as a reference across gels. Intensities were quantified and normalized to GSK3b for pGSK3b levels (b), normalized to GSK3a for pGSK3a levels (d) and normalized to b-actin for GSK3b levels (c) and GSK3a levels (e). Data represent mean ± s.e. BPI, type I bipolar disorder; BPII, type II bipolar disorder; MDD, major depressive disorder; MiDD, minor depressive disorder; Other, postpartum psychosis or liability not confirmed; Normal, unaffected healthy controls. **P = 0.002, adjusted by passage.
level of phosphorylated GSK3b may contribute to the pathogenesis of bipolar disorder, at least in the Amish pedigree with bipolar disorder. The observed reduced level of p-GSK3b, thus higher GSK3b activity in bipolar fibroblasts, may also underlie the rationale for lithium treatment of bipolar disorder since lithium directly inhibits GSK3b resulting in N-terminal phosphorylation of GSK3b at serine 9.
61 It was reported that the level of p-GSK3b in peripheral blood mononuclear cells from subjects with bipolar disorder under lithium treatment is significantly higher than that in healthy control subjects, 100 although no difference was detected between lithium-free bipolar and healthy controls. We postulate that the genetically heterogeneous nature of the samples may account for the failure of detecting p-GSK3b level difference between lithiumfree bipolar and healthy controls, as we encountered when including samples from members of non-Amish family 884 in our analysis. Many studies have revealed the role of GSK3b in regulating circadian period 24, [27] [28] [29] and circadian phase. 25, 26 Further investigation is needed to address whether the reduced p-GSK3b level in BP fibroblasts is responsible for the subtle alterations in circadian gene expression as observed in this study.
Recently, gene expression profiling showed that adult fibroblasts encode positional identity relative to embryonic developmental axes, that is, gene expression in fibroblasts showed site-specific variations related to the anatomical divisions: anterior-posterior; proximal-distal and dermal vs non-dermal. 79 In our experiment, information on the biopsy site was largely unavailable (only 6 of the 24 cell lines were known) and therefore, we were not able to perform covariate analyses on this parameter. However, examination of rhythmically expressed genes assayed in our study (BMAL1, PER1, PER2, REV-ERBa, DEC2 and DBP) in the expression profiling data on adult fibroblasts from different body sites 79 showed that none of these genes were differentially expressed in fibroblasts originated from different part of the body. Moreover, these genes did not show a significant variation in the level of mRNA among the primary fibroblasts donors that were of heterogeneous genetic background (Rinn and Chang, unpublished data). Therefore, we do not expect that the ambiguity about the anatomical site of the biopsy and the genetic heterogeneity will represent confounding factors in our analysis of cycling gene expression.
Despite the advantage of using fibroblasts derived from human biopsies to study the circadian clock function, we are aware of several limitations. Validation of the fibroblast model as a readout of the core clock machinery comes from experiments showing that genetic differences can be manifested in both central and peripheral oscillators. 64, 70, 72 However, we cannot assume that all circadian changes detected in fibroblasts will translate to physiological and behavioral anomalies. 71 Therefore, caution is needed to extend our results from fibroblasts to CNS mechanisms and overt behavior. Anomalies in clockcontrolled genes or in the mechanism that regulates sleep homeostasis may also lead to the altered physiology and behavior observed in bipolar disorder. Another limitation is related to the nature of the patient population available for our studies. By using cell lines collected from unidentified individuals, we were unable to obtain information on disease state (manic, euthymic or depressive phase) or therapy (that is, lithium treatment). Finally, the sample size used in our study (12 BPI vs 12 MC for circadian expression analysis) was relatively small; the study should be repeated on a large scale.
In summary, we found that the core circadian clock is functional in fibroblasts derived from bipolar patients. However, a decrease in overall levels of circadian gene expression; a trend toward reduced amplitude of circadian gene expression; and a decrease in GSK3b phosphorylation in fibroblasts derived from bipolar patients provide preliminary evidence for a link between the core circadian system and bipolar disorder. We propose that these anomalies, through downstream effects, may contribute to altered circadian rhythms as reported in bipolar patients 13, 94, 95 and may be involved in the etiology of the disorder.
